+ mice, on the wildtype, miR-29a heterozygous and miR-29a knockout backgrounds, were monitored for pancreatic cancer growth by MRI every two weeks. Total tumour volume was estimated at each time-point for (A) wildtype Ela1-TAg + female mice, (B) miR-29a heterozygous Ela1-TAg + female mice, (C) miR-29a knockout Ela1-TAg + female mice, (D) wildtype Ela1-TAg + male mice, (E) miR-29a heterozygous Ela1-TAg + male mice, and (F) miR-29a knockout Ela1-TAg + male mice (n = 24, 11, 9, 21, 14, 10). Each line indicates tumour size in a single mouse.
